CN1961927B - 一种治疗气管-支气管急慢性炎症药物组合物及制备方法 - Google Patents
一种治疗气管-支气管急慢性炎症药物组合物及制备方法 Download PDFInfo
- Publication number
- CN1961927B CN1961927B CN200510115663A CN200510115663A CN1961927B CN 1961927 B CN1961927 B CN 1961927B CN 200510115663 A CN200510115663 A CN 200510115663A CN 200510115663 A CN200510115663 A CN 200510115663A CN 1961927 B CN1961927 B CN 1961927B
- Authority
- CN
- China
- Prior art keywords
- weight portion
- pharmaceutical composition
- weight
- concentrated
- volatile oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 208000038016 acute inflammation Diseases 0.000 title claims description 7
- 230000006022 acute inflammation Effects 0.000 title claims description 7
- 208000037976 chronic inflammation Diseases 0.000 title claims description 7
- 230000006020 chronic inflammation Effects 0.000 title claims description 7
- 238000000034 method Methods 0.000 claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 62
- 206010011224 Cough Diseases 0.000 claims description 51
- 210000000582 semen Anatomy 0.000 claims description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 44
- 239000008187 granular material Substances 0.000 claims description 39
- 239000003814 drug Substances 0.000 claims description 35
- 239000000341 volatile oil Substances 0.000 claims description 35
- 239000000796 flavoring agent Substances 0.000 claims description 20
- 235000019634 flavors Nutrition 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 16
- 238000001035 drying Methods 0.000 claims description 14
- 239000003921 oil Substances 0.000 claims description 14
- 229920000858 Cyclodextrin Polymers 0.000 claims description 13
- 238000004821 distillation Methods 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 206010062717 Increased upper airway secretion Diseases 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 208000026435 phlegm Diseases 0.000 claims description 11
- 238000001556 precipitation Methods 0.000 claims description 11
- 239000001116 FEMA 4028 Substances 0.000 claims description 10
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 10
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 10
- 229960004853 betadex Drugs 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 238000011282 treatment Methods 0.000 claims description 9
- 230000000954 anitussive effect Effects 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 7
- 238000001256 steam distillation Methods 0.000 claims description 7
- 206010030113 Oedema Diseases 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 229950005162 benexate Drugs 0.000 claims description 6
- IAXUQWSLRKIRFR-SAABIXHNSA-N chembl2104696 Chemical compound C1C[C@@H](CNC(=N)N)CC[C@@H]1C(=O)OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 IAXUQWSLRKIRFR-SAABIXHNSA-N 0.000 claims description 6
- 230000006837 decompression Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000004064 recycling Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 206010061218 Inflammation Diseases 0.000 claims description 4
- 239000000890 drug combination Substances 0.000 claims description 4
- 230000004054 inflammatory process Effects 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000010894 Artemisia argyi Nutrition 0.000 abstract description 28
- 244000030166 artemisia Species 0.000 abstract description 28
- 230000001154 acute effect Effects 0.000 abstract description 5
- 206010044302 Tracheitis Diseases 0.000 abstract description 4
- 206010006451 bronchitis Diseases 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 3
- 235000007650 Aralia spinosa Nutrition 0.000 abstract 1
- 241001465251 Ephedra sinica Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 235000009827 Prunus armeniaca Nutrition 0.000 abstract 1
- 244000018633 Prunus armeniaca Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 241000949456 Zanthoxylum Species 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000008216 herbs Nutrition 0.000 abstract 1
- 235000014676 Phragmites communis Nutrition 0.000 description 29
- 238000012360 testing method Methods 0.000 description 24
- 238000002474 experimental method Methods 0.000 description 17
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- 229960004756 ethanol Drugs 0.000 description 15
- 238000000605 extraction Methods 0.000 description 15
- 241000699670 Mus sp. Species 0.000 description 14
- 229940079593 drug Drugs 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 10
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 8
- 235000012907 honey Nutrition 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 7
- 241000700199 Cavia porcellus Species 0.000 description 6
- 241000700159 Rattus Species 0.000 description 6
- 206010057190 Respiratory tract infections Diseases 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 235000010418 carrageenan Nutrition 0.000 description 6
- 229920001525 carrageenan Polymers 0.000 description 6
- 210000002683 foot Anatomy 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000007670 refining Methods 0.000 description 6
- 230000009385 viral infection Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 230000000241 respiratory effect Effects 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 4
- 238000000540 analysis of variance Methods 0.000 description 4
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 4
- 229960003321 baicalin Drugs 0.000 description 4
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 4
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 229960002179 ephedrine Drugs 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 235000019353 potassium silicate Nutrition 0.000 description 4
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 210000003437 trachea Anatomy 0.000 description 4
- 238000012449 Kunming mouse Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 230000000242 pagocytic effect Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000008570 maxingshigan Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- 244000101724 Apium graveolens Dulce Group Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014025 Ear swelling Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 1
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510115663A CN1961927B (zh) | 2005-11-09 | 2005-11-09 | 一种治疗气管-支气管急慢性炎症药物组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200510115663A CN1961927B (zh) | 2005-11-09 | 2005-11-09 | 一种治疗气管-支气管急慢性炎症药物组合物及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1961927A CN1961927A (zh) | 2007-05-16 |
CN1961927B true CN1961927B (zh) | 2010-05-05 |
Family
ID=38081267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200510115663A Expired - Fee Related CN1961927B (zh) | 2005-11-09 | 2005-11-09 | 一种治疗气管-支气管急慢性炎症药物组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1961927B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103989904A (zh) * | 2014-04-22 | 2014-08-20 | 安徽省太湖山中药饮片有限公司 | 一种治疗慢性支气管炎的中药组合物 |
CN107789379A (zh) * | 2017-11-18 | 2018-03-13 | 马述腾 | 一种艾蒿提取物足浴泡腾片 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083724A (zh) * | 1993-07-14 | 1994-03-16 | 邢炳荣 | 一种治疗老年性慢性支气管炎的中药丸 |
CN1163769A (zh) * | 1996-04-30 | 1997-11-05 | 胡毓恒 | 一种治疗气管炎、肺气肿的脐疗药囊 |
CN1262115A (zh) * | 1999-02-04 | 2000-08-09 | 李玉海 | 小儿平喘止咳合剂 |
CN1431000A (zh) * | 2003-01-28 | 2003-07-23 | 吴逊 | 止咳贴膏 |
-
2005
- 2005-11-09 CN CN200510115663A patent/CN1961927B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1083724A (zh) * | 1993-07-14 | 1994-03-16 | 邢炳荣 | 一种治疗老年性慢性支气管炎的中药丸 |
CN1163769A (zh) * | 1996-04-30 | 1997-11-05 | 胡毓恒 | 一种治疗气管炎、肺气肿的脐疗药囊 |
CN1262115A (zh) * | 1999-02-04 | 2000-08-09 | 李玉海 | 小儿平喘止咳合剂 |
CN1431000A (zh) * | 2003-01-28 | 2003-07-23 | 吴逊 | 止咳贴膏 |
Non-Patent Citations (2)
Title |
---|
居来提等.麻黄杏仁甘草石膏汤加味治疗急性支气管炎50例.农星医学25 3.2003,25(3),第179-180页. |
居来提等.麻黄杏仁甘草石膏汤加味治疗急性支气管炎50例.农星医学25 3.2003,25(3),第179-180页. * |
Also Published As
Publication number | Publication date |
---|---|
CN1961927A (zh) | 2007-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103768308B (zh) | 一种用于治疗上呼吸道感染的药物组合物及其制备方法 | |
CN101869612A (zh) | 麻杏石甘口服液及其制备方法 | |
CN103169891A (zh) | 一种新型维c银翘片 | |
CN100409882C (zh) | 一种清热解毒退烧药物 | |
CN101053619B (zh) | 一种治疗肺纤维化的药物 | |
CN1961927B (zh) | 一种治疗气管-支气管急慢性炎症药物组合物及制备方法 | |
CN102357158A (zh) | 一种防治鸡传染性喉气管炎病的药物及其制备方法 | |
CN116139237B (zh) | 一种防治新型冠状病毒等所致呼吸道感染的中药组合物及其应用 | |
CN101152379B (zh) | 一种治疗咳嗽病的中药及其制备工艺 | |
CN102526236B (zh) | 一种治疗流行性感冒的药物及其制备方法 | |
CN104771745A (zh) | 一种治疗腹泻的中药组合物及其制备方法和应用 | |
CN103040939B (zh) | 一种治疗感冒的中药组合物及其制备方法和用途 | |
CN103432386B (zh) | 一种治疗咳嗽的中药制剂及其制备方法 | |
CN102451401A (zh) | 一种维c银翘的处方 | |
CN103610897A (zh) | 一种治疗止咳祛痰的中药组合物及其制备方法和应用 | |
CN102988729A (zh) | 一种治疗肺炎的中药组合物 | |
CN103656137A (zh) | 一种散风解热止嗽化痰的中药组合物及其制备方法 | |
CN100515490C (zh) | 一种治疗支气管哮喘的纯中药制剂 | |
CN106237297A (zh) | 一种用于治疗慢性支气管炎的药物组合物 | |
CN102058768B (zh) | 一种清肺化痰止嗽定喘的中药组合物及制备方法 | |
CN105327198A (zh) | 一种清热止咳保健茶及其制备方法和应用 | |
CN1438017A (zh) | 一种治疗感冒的药物及其制备方法 | |
CN104257956A (zh) | 一种止咳平喘的中药组合物 | |
CN104644659A (zh) | 20(R)-人参皂苷Rg3在制备咽炎药物中的应用 | |
CN104547575A (zh) | 治疗毛细支气管炎合并腹泻的中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ABMAX BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: BEIJING JINSHI WEIKANG MEDICAL TECHNOLOGY CO., LTD. Effective date: 20150515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100088 HAIDIAN, BEIJING TO: 101111 DAXING, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150515 Address after: The 101111 Beijing economic and Technological Development Zone Branch 14 Street No. 99 18-2-201 Patentee after: ABMAX BIOTECHNOLOGY Co.,Ltd. Address before: 100088, C, 12 South College Road, Beijing, Haidian District Patentee before: BEIJING JINSHI WEIKANG MEDICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180209 Address after: 100082 Beijing wenhuiyuan Haidian District Road No. 10 building 201 Beijing Normal University Patentee after: BEIJING JINSHI WEIKANG MEDICAL TECHNOLOGY Co.,Ltd. Address before: The 101111 Beijing economic and Technological Development Zone Branch 14 Street No. 99 18-2-201 Patentee before: ABMAX BIOTECHNOLOGY Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100505 |
|
CF01 | Termination of patent right due to non-payment of annual fee |